InsiderTrades

Form 4 for CTKB Cytek Biosciences, Inc.

Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-11 · accession 0001415889-24-007868 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-13 2024-03-11 CTKB Poirson Allen SVP BUS. AND CORP. DEV F - Tax $7.22 -1,301 51.1K -2% -$9,393
D 2024-03-13 2024-03-11 CTKB Poirson Allen SVP BUS. AND CORP. DEV M - OptEx — +3,338 52.4K +7% —
D 2024-03-13 2024-03-11 CTKB Poirson Allen SVP BUS. AND CORP. DEV M - OptEx $0.00 -3,338 30.0K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-11 F D 1,301 $7.22 51,055 D — — (F2) Represents the number of shares withheld by and surrendered to the Issuer on March 11, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
2 Common Common Stock 2024-03-11 M A 3,338 — 52,356 D — — (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
3 Derivative Restricted Stock Units 2024-03-11 M D 3,338 $0.00 30,043 D — · — to — 3,338 Common Stock (F1) Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock. (F3) The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.